Navigation Links
Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Date:1/10/2014

GLENDALE, Wis., Jan. 10, 2014 /PRNewswire/ -- Crealta Pharmaceuticals LLC ("Crealta"), a new specialty pharmaceutical company, announced today the completion of the acquisition of substantially all of the assets of Savient Pharmaceuticals, Inc. ("Savient"). Crealta previously announced the winning of an auction for these assets, the signing of a definitive acquisition agreement with Savient, and the subsequent approval of the transaction by the U.S. Bankruptcy Court for the District of Delaware.

The key asset acquired by Crealta is KRYSTEXXA (pegloticase), a novel biologic product that was approved by the FDA in 2010. KRYSTEXXA is a PEGylated uric acid specific enzyme, or uricase, that has been shown to statistically significantly reduce uric acid levels for many patients with refractory chronic gout.

"We are tremendously excited to have completed the transaction, and more importantly, to ensure the continued availability of this critical product," commented Ed Fiorentino, Chairman and CEO of Crealta. "Crealta is committed to providing outstanding support and service to healthcare professionals and the patients that they serve with refractory chronic gout."

Crealta was established in August 2013 in partnership with GTCR, one of the nation's leading private equity firms.

KRYSTEXXA IMPORTANT SAFETY INFORMATION

The following information is provided in both the U.S. and European prescribing information.

KRYSTEXXA is not indicated for the treatment of asymptomatic hyperuricemia. KRYSTEXXA is indicated for adults who have tried or cannot take oral gout medications and still have high uric acid levels and signs and symptoms of gout. Patients who have a genetic condition known as G6PD deficiency should not use KRYSTEXXA.

Discontinue oral urate-lowering therapies before instituting KRYSTEXXA and do not institute oral urate-lowering the
'/>"/>

SOURCE Crealta Pharmaceuticals LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals
2. Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704
3. Novartis Pharmaceuticals Corporation stands behind medication adherence activities and reaffirms commitment to patient safety
4. Upcoming Conferences, Share Price Updates, and Leadership Changes - Research Report on Lilly, Allergan, Waters, Novavax, and Supernus Pharmaceuticals
5. Auxilium Pharmaceuticals, Inc. To Present At The J.P. Morgan 32nd Annual Healthcare Conference
6. Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics
8. Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
9. Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13
10. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
11. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015  Boston Scientific Corporation (NYSE: BSX ... momentum and long-term growth strategies at a meeting with ... City . President and Chief Executive Officer ... company has to bring forward meaningful innovation to transform ... deliver shareholder value. "We are focused ...
(Date:5/1/2015)... N.J., May 1, 2015 Cambrex Corporation (NYSE: ... 31, 2015. Highlights , Sales ... increased 27% excluding foreign currency impact, driven by Innovator products ... from $8.4 million in the first quarter of 2014. ... $0.04 in the first quarter last year and Adjusted Diluted ...
(Date:4/30/2015)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider ... today announced results for its first quarter ended March ... first quarter of 2015 was $116.2 million, up $14.5 ... and down $5.3 million or 4.4% from the fourth ... income as reported in accordance with U.S. generally accepted ...
Breaking Medicine Technology:Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20
... If you,re thinking about cosmetic surgery, your first stop ... into the future.   SculptMyDream.com is the first website ... using actual 3D photography.  Not only will this help you ... who can turn that dream into reality. (Photo: ...
... Berkery Noyes , the leading independent investment ... released its Half Year Mergers and Acquisitions Trends Report for ... The report analyzes merger and acquisition activity in ... first half of 2011 and compares it with activity in ...
Cached Medicine Technology:See the Results of Your Breast Augmentation, Before Surgery 2Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry 2
(Date:5/3/2015)... BolehVPN ” was featured on NewsWatch as part of its ... products available to consumers. Scott Steinberg, a technology expert and ... viewers how to protect their private information. , A lot ... even more so online. It helps everyone stay connected with ... In terms of work, the internet makes things more efficient. ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 It is not ... Annual Brain Aneurysm Walk in Memory of Lissa Anne Been ... Lissa organized this great family-friendly event to honor her loving memory. ... its inception. , Just having turned 37, Lissa suffered a ... passed away on August 24, 2012. This event is designed to ...
(Date:5/2/2015)... BC (PRWEB) May 02, 2015 Vancouver fencing ... will now provide valuable advice to prospective clients related to ... are looking to install railings around their decks and patios. ... several questions that pop up once the person rolls up ... phases of installing a railing in finding a gate that ...
(Date:5/2/2015)... 2015 We are pleased to announce ... Center as one of the Top Workplaces of 2015. ... addiction treatment field for their ethics and standards of ... to continue their educational efforts. The Delray Recovery Center ... forgetting their purpose – to help individuals heal from ...
(Date:5/2/2015)... TX (PRWEB) May 02, 2015 ... skin laxity issues of the face, neck and ... new concept with real potential for the success ... by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s ... FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... , THURSDAY, March 15 (HealthDay News) -- Eating ... in fried foods, baked goods and other prepared meals and ... -- behavior, new research suggests. In conducting the study, ... Medicine analyzed the diet and behavior of 945 men and ...
... DENVER Patients with early stage malignant pleural mesothelioma ... the lungs, may be eligible for aggressive multi-modality therapy ... approaches, and controversy has existed about which approach is ... extensive surgery where surgeons remove the entire diseased lung, ...
... in the gym, surrounded by others, pounding to the beat in ... when it comes to the experience of changing in the locker ... front of others, can be very discomfiting. It,s a complex experience ... than in any other space. "I walk into the change ...
... alcohol consumption has been consistently associated with lower risk ... certain, especially among women. A total of 83,578 ... free of diagnosed cardiovascular disease and cancer at baseline ... alcohol consumption were assessed at baseline and updated approximately ...
... there is a clear relationship between androgenetic alopecia (common ... enlargement of the prostate that appears in aging men ... condition appears in 50% of men over 60 year ... In the light of the study published in the ...
... A 21,626-person study published today in the Journal ... rate for children and adolescents with acute lymphoblastic leukemia ... percent in those diagnosed during the years 1990-1994, to ... "The improved survival is due to using existing ...
Cached Medicine News:Health News:Could Trans Fats Make You Cranky? 2Health News:Pleurectomy/decortication proposed preferred surgical procedure 2Health News:The stress of undress 2Health News:The stress of undress 3Health News:Moderate drinking associated with lower risk of stroke in women 2Health News:A study confirms the correlation between premature alopecia and prostate conditions 2Health News:Largest ever study of childhood ALL shows improving survival 2
... tiny, water-resistant monitor captures the data you ... ,Requiring only five electrodes, the DigiTrak ... the entire patient test, which can be ... AA battery. Three channels of ECG recording ...
... biograph 6 offers the ultimate ... diagnosis and treatment in oncology, ... high-quality PET/CT whole body scans ... Our comprehensive suite of clinical ...
... Lunar DPX Duo is a SmartBeam platform ... get measurements of the two most clinical ... seconds, and at a low radiation dose., ... based on Windows, optimizes productivity and ensures ...
... ScImage's PICOMEnterprise is a web-enabled ... custom reporting and custom workflow integration. ... captures, stores, distributes and archives images, ... any DICOM and many non-DICOM devices ...
Medicine Products: